When greed isn’t good: lessons from pharma’s fall
Investor's Digest of Canada •2016-05-12 •
Reflecting on the rise and fall of one-time TSX favourite healthcare stock Valeant Pharmaceuticals, performance improvement specialist Sam Watts warns readers that a company’s continuous acquisitions can cause management to Read More